- Poster presentations showcase SAFEbody® precision masking technology applicability across targets and modalities –
- IND or equivalent filings planned for two new product candidates in 2022, including masked anti-CD137 antibody with Fc engineering and masked anti-CD47 antibody, designed to enhance both safety and efficacy -
Read more at globenewswire.com